SK

Sanjeev Kumar

Active Director Director DIN 02240444
DIN 02240444 First appointment Jan 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2016
Shareholding value •••• Premium profile

About Sanjeev Kumar

Data last updated:

Sanjeev Kumar is a Director at Shreeon Pharma Private Limited (since 2016). The company operates in Pharma. Shreeon Pharma Private Limited reported revenue of ₹22 Lakh (FY 2024).

DIN 02240444
Primary Designation Director
Industry Pharma
First Appointment 25 Jan 2016
Oldest Company Age 10 yrs
Largest company Shreeon Pharma Private Limited · ₹22 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shreeon Pharma Private Limited U51101MH2016PTC272383
Director25 Jan 20162016₹22 Lakh (FY 2024)Active

Board colleagues of Sanjeev Kumar

NameDINCompanyDesignation
Sabita Kumari07337136Shreeon Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shreeon Pharma Private Limited
Premium access

Shareholding and investment profile for Sanjeev Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjeev Kumar

Sanjeev Kumar currently holds 1 directorship: Shreeon Pharma Private Limited (Director, since 25 Jan 2016, revenue ₹22 Lakh (FY 2024)).

Sanjeev Kumar was first appointed on 25 Jan 2016 as Director at Shreeon Pharma Private Limited.

The current boards of Sanjeev Kumar's companies include Sabita Kumari (Shreeon Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available